What to watch with FTO and sleep?

FTO variants (e.g., rs9939609) are strongly linked to obesity, but direct evidence for an effect on sleep is weak. Some GWAS show marginal associations with sleep duration or quality, but effect sizes are small and not clinically actionable. More importantly, sleep deprivation alters appetite-regulating hormones like ghrelin and leptin, and FTO carriers may be more sensitive to these changes. The takeaway: prioritize adequate sleep (7–9 h) to support weight management, but there is no specific 'FTO sleep risk' to watch. No DNA test can tell you your optimal sleep duration. The evidence is primarily GWAS-based, not causal. Be wary of overblown claims – good sleep hygiene matters regardless of genotype.